As of Jun 30
| +0.11 / +2.44%|
The 2 analysts offering 12-month price forecasts for Alimera Sciences Inc have a median target of 11.00, with a high estimate of 12.00 and a low estimate of 10.00. The median estimate represents a +138.61% increase from the last price of 4.61.
The current consensus among 3 polled investment analysts is to Buy stock in Alimera Sciences Inc. This rating has held steady since June, when it was unchanged from a Move your mouse over past
months for detail
Move your mouse over a quarter or year to see how estimates have changed over time.